Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01075
Species: Homo sapiens
Position : chr21:36399106-36399322
Year: 2019
Title: RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: acute myeloid leukemia
PMID:  31023702
MONDO: MONDO:0018874
Tissue: bone marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: primary RUNX1-mutant AML
Cell Type: AML cell
Experiment Type: Endogenous enhancer editing; enhancer dependency; leukemia survival analysis
High Throughput Method: ChIP-seq; H3K27ac profiling; RNA-seq; Hi-C data integration
Low Throughput Method: CRISPR/Cas9 eR1 editing-out; qRT-PCR; western blot; proliferation assay; apoptosis assay; colony-forming assay
About Target Gene
Target gene : RUNX1
About TF
TF name : RUNX1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
RUNX1 AndrogenReceptor netpath 167
RUNX1 Organic cation transport reactome 9
RUNX1 RANKL netpath 84
RUNX1 Regulation of nuclear SMAD2/3 signaling pid 82
RUNX1 TGF_beta_Receptor netpath 220
RUNX1 Validated transcriptional targets of deltaNp63 isoforms pid 47
RUNX1 Pathways in cancer kegg 321
RUNX1 Chronic myeloid leukemia kegg 69
RUNX1 Acute myeloid leukemia kegg 53
Enhancer Associated Network
Overlapping Enhancers (hg19) 5 found
Enhancer ID Position Tissue Cell Disease
E_01080 chr21:36399106-36399322 bone marrow AML cell acute myeloid leukemia
E_01084 chr21:36399106-36399322 bone marrow myeloid leukemia cell acute myeloid leukemia
E_01085 chr21:36399106-36399322 blood myeloid leukemia cell acute myeloid leukemia
E_01086 chr21:36399106-36399322 bone marrow myeloid leukemia cell acute myeloid leukemia
E_01087 chr21:36399106-36399322 blood myeloid leukemia cell acute myeloid leukemia
Expression of Target Genes for the Enhancer